AU2021210867A1 - Dosing regimens and methods for treating cancer - Google Patents

Dosing regimens and methods for treating cancer Download PDF

Info

Publication number
AU2021210867A1
AU2021210867A1 AU2021210867A AU2021210867A AU2021210867A1 AU 2021210867 A1 AU2021210867 A1 AU 2021210867A1 AU 2021210867 A AU2021210867 A AU 2021210867A AU 2021210867 A AU2021210867 A AU 2021210867A AU 2021210867 A1 AU2021210867 A1 AU 2021210867A1
Authority
AU
Australia
Prior art keywords
2dehspm
cancer
treatment
patient
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021210867A
Other languages
English (en)
Inventor
Michael T. CULLEN
Suzanne Gagnon
Thomas X. Neenan
Michael Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uswm LLC
Original Assignee
Uswm LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uswm LLC filed Critical Uswm LLC
Publication of AU2021210867A1 publication Critical patent/AU2021210867A1/en
Assigned to USMW, LLC reassignment USMW, LLC Amend patent request/document other than specification (104) Assignors: Panbela Therapeutics, Inc.
Assigned to USWM, LLC reassignment USWM, LLC Amend patent request/document other than specification (104) Assignors: USMW, LLC
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2021210867A 2020-01-20 2021-01-20 Dosing regimens and methods for treating cancer Pending AU2021210867A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062963492P 2020-01-20 2020-01-20
US62/963,492 2020-01-20
PCT/US2021/014112 WO2021150559A1 (en) 2020-01-20 2021-01-20 Dosing regimens and methods for treating cancer

Publications (1)

Publication Number Publication Date
AU2021210867A1 true AU2021210867A1 (en) 2022-08-18

Family

ID=76992702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021210867A Pending AU2021210867A1 (en) 2020-01-20 2021-01-20 Dosing regimens and methods for treating cancer

Country Status (6)

Country Link
US (1) US20230064990A1 (https=)
EP (1) EP4093386A4 (https=)
JP (1) JP2023512487A (https=)
AU (1) AU2021210867A1 (https=)
CA (1) CA3164914A1 (https=)
WO (1) WO2021150559A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026501282A (ja) * 2022-12-20 2026-01-14 ジェネンテック， インコーポレイテッド Ｐｄ－１軸結合アンタゴニストおよびｒｎａワクチンを用いて膵臓がんを処置する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160022A (en) * 1999-07-19 2000-12-12 University Of Florida Chemical resection of pancreas
US20130137772A1 (en) * 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
WO2017062704A1 (en) * 2015-10-08 2017-04-13 Sun Biopharma, Inc. Compositions and methods for treating pancreatitis
US10195188B2 (en) * 2016-06-13 2019-02-05 Chemocentryx, Inc. Method of treating pancreatic cancer
EP4257581A1 (en) * 2018-01-30 2023-10-11 Panbela Therapeutics, Inc. Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol

Also Published As

Publication number Publication date
EP4093386A1 (en) 2022-11-30
EP4093386A4 (en) 2024-01-10
WO2021150559A1 (en) 2021-07-29
US20230064990A1 (en) 2023-03-02
JP2023512487A (ja) 2023-03-27
CA3164914A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
US11980652B2 (en) Compositions and methods for subcutaneous administration of cancer immunotherapy
CN110475571A (zh) 细胞免疫疗法前细胞毒性预调理的替代
WO2019124500A1 (ja) Ｔｌｒ７アゴニストを含む併用薬
JP2019508444A (ja) 医療において使用するための、免疫チェックポイントモジュレータと、細胞透過性ペプチド、カーゴ、及びｔｌｒペプチドアゴニストを含む複合体との組合せ
JP2018508572A (ja) 免疫チェックポイント阻害薬と併用するプリナブリンの使用
US20250032582A1 (en) Compositions and methods for cancer immunotherapy
US20230064990A1 (en) Dosing regimens and methods for treating cancer
CA3117064A1 (en) Guanabenz as an adjuvant for immunotherapy
EP4135748A1 (en) Immunostimulatory agents in combination with angiogenesis inhibitors
US20230181633A1 (en) Methods of treating cancer using a combination of tumor membrane vesicles and metformin
WO2025207491A1 (en) Compositions and methods for cancer immunotherapy
US20210338656A1 (en) Immunostimulatory agents in combination with angiogenesis inhibitors

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: USMW, LLC

Free format text: FORMER NAME(S): PANBELA THERAPEUTICS, INC.

HB Alteration of name in register

Owner name: USWM, LLC

Free format text: FORMER NAME(S): USMW, LLC